Skip to main content
. 2020 Mar 6;19(5):3203–3210. doi: 10.3892/etm.2020.8574

Figure 1.

Figure 1

Expression of miR-106b-5p in OS clinical samples and cell lines. (A) Expression of miR-106b-5p in 18 pairs of human OS tissue and adjacent tissue, as determined via reverse transcription-quantitative PCR. ***P<0.001 as indicated. (B) Expression of miR-106b-5p in OS cells lines (MG-63, U2OS, SW1353 and Saos-2) and an osteoblast cell line hFOB1.19 is presented. Data are represented as the mean ± standard deviation. **P<0.01 and ***P<0.001 vs. hFOB1.19 cell line. miR, microRNA; OS, osteosarcoma.